All stocks · HINDBIO
HB

Hindustan Bio Sciences Ltd.

HINDBIO BSE Drug Manufacturers - Specialty & Generic Healthcare

Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology…

ISIN INE597C01021
Listed —
Quarters tracked 13
Filings 19 docs

About

Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.

Quarterly Results

Rs. Crores · hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 0.00 0.00 0.38 0.00 0.32 0.38 0.00 0.41 0.41 0.39 0.32 0.32 0.00
Expenses 0.11 0.11 0.31 0.06 0.32 0.28 0.04 0.34 0.34 0.35 0.26 0.26 0.12
Operating Profit -0.11 -0.11 0.07 -0.06 0.00 0.10 -0.04 0.07 0.07 0.04 0.06 0.06 -0.12
OPM % — — 18.42 — 0.00 26.32 — 17.07 17.07 10.26 18.75 18.75 —
Other Income 0.00 0.00 0.02 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00
Depreciation 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.11 -0.11 0.08 -0.05 0.01 0.11 -0.04 0.08 0.08 0.04 0.07 0.07 -0.12
Tax % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit -0.11 -0.12 0.08 -0.06 0.01 0.11 -0.04 0.08 0.08 0.04 0.07 0.07 -0.12
EPS in Rs -0.11 -0.12 0.08 -0.06 0.01 0.11 -0.04 0.08 0.08 0.04 0.07 0.07 -0.12

Profit & Loss

Annual · Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 0.740.811.050.920.431.031.943.561.031.011.260.75
Expenses 0.800.710.990.950.941.971.803.433.381.481.381.97
Operating Profit -0.060.100.06-0.03-0.51-0.940.140.13-2.35-0.47-0.12-1.22
OPM % -8.1112.355.71-3.26-118.60-91.267.223.65-228.16-46.53-9.52-162.67
Other Income 0.000.000.000.000.000.000.000.000.090.00-1.92-0.01
Interest 0.000.000.000.000.000.010.010.010.000.010.030.03
Depreciation 0.020.000.010.010.000.010.010.010.010.010.010.18
Profit before tax -0.080.100.05-0.04-0.51-0.960.120.11-2.27-0.49-2.08-1.44
Tax % 0.000.000.000.000.00-2.0833.330.000.000.000.000.69
Net Profit -0.080.100.06-0.04-0.52-0.940.080.11-2.28-0.49-2.09-1.46
EPS in Rs -0.080.100.06-0.04-0.51-0.920.080.11-2.22-0.48-2.04-1.42
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 2.052.052.052.0510.2510.2510.2510.2510.2510.2510.2510.25
Reserves -1.22-1.15-1.25-1.30-9.46-8.95-8.01-8.09-8.20-5.92-5.43-3.34
Borrowings 2.352.512.562.462.171.862.603.371.571.300.940.97
Other Liabilities 0.020.010.010.080.020.320.710.100.090.240.120.17
Total Liabilities 3.203.423.373.292.983.485.555.633.715.875.888.05
Fixed Assets 0.010.030.030.030.040.040.050.060.060.060.070.08
CWIP 0.000.000.000.000.000.000.000.000.000.000.001.92
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 3.193.393.343.262.943.445.505.573.655.815.816.05
Total Assets 3.203.423.373.292.983.485.555.633.715.875.888.05

Cash Flows

Annual · Rs. Crores — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 0.280.03-1.41-0.05-0.340.750.82-1.32-0.23-0.160.46-0.27
Cash from Investing Activity -0.010.000.000.000.000.000.00-0.010.000.000.000.00
Cash from Financing Activity -0.16-0.051.430.050.34-0.93-0.811.500.210.18-0.630.30
Net Cash Flow 0.12-0.020.030.00-0.01-0.180.010.17-0.020.01-0.170.03
Free Cash Flow 0.270.03-1.41-0.05-0.340.750.82-1.33-0.23-0.160.46-0.27
CFO/OP % -467.0030.00-2,350.00167.0067.00-78.00600.00-1,015.0010.0034.00-383.0022.00

Ratios

Annual · Days / % — latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 24.66198.27152.95178.53118.84219.71255.88171.22113.40169.85136.15155.73
Inventory Days 0.000.000.000.000.000.0095.4613.8951.230.000.0025.08
Days Payable ——————185.317.5844.82——39.01
Cash Conversion Cycle 24.66198.27152.95178.53118.84219.71166.03177.54119.80169.85136.15141.80
Working Capital Days 305.81441.60312.86-226.14-500.81-148.8386.5585.10-170.10-191.53-63.73111.93
ROCE % -2.432.951.52-1.30-16.67-23.752.512.62-49.08-8.43-1.91-16.40

Shareholding Pattern

% holding — latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19
Public 87.81 87.80 87.81 87.81 87.81 87.80 87.82 87.81 87.81 87.82 87.81 87.81
No. of Shareholders 11,707 11,530 11,516 11,405 11,620 11,246 11,276 11,618 11,779 10,921 10,315 9,253

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (₹)Notes
Other 03 Mar 2023 03 Mar 2023 — — Reduction of Capital

Announcements

5 filings

Shareholding Pattern

Open on BSE

Financial Results — Filings

Open on BSE

Board Filings

Open on BSE

Annual Reports

Back to all stocks